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Background: The green fluorescence protein (GFP)-associated fluorescence method and the luciferase-associated
bioluminescence method are the two major methods for IVIS imaging system to investigate the bacterial infection
in animal models. The aim of this study was to evaluate the infection route of Gram-negative bacteria carrying a
stable and broad range of conjugative bioluminescence plasmid pSE-Lux1 in a mouse model.
Results: Both encapsulated and non-encapsulated Gram-negative bacteria were used as hosts to evaluate conjugation
efficiency and plasmid stability of pSE-Lux1, a recombinant of pSE34 and luxABCDE operon. The plasmid conjugation
efficiencies of pSE-Lux1 ranged from 10−3 to 10−7 in various Gram-negative bacteria. Plasmid pSE-Lux1 maintained in
Escherichia coli, Klebsiella pneumoniae, and Salmonella enterica serovars Choleraesues (abbreviated S. Choleraesuis) and
Typhimurium (S. Typhimurium), than in Acinetobacter baumannii and Serratia marcescens, was shown to be of better
stability for at least four days. To investigate systemic bacterial infections, K. pneumoniae strain CG354 was intravenously
injected, and then was clearly observed to be non-pathogenic to Balb/c mice for a long-term bioluminescence
monitoring for 6 days. For examining dynamic distributions of gastrointestinal tract infection, the invasion protein
SipB-deficient mutant OU5045△sipB and OU5046△sipB of S. serovar Typhimurium constructed in this study, compared
to wild-type strain OU5045 and its virulence plasmid-less strain OU5046, were of less virulence to mice.
Conclusions: This is the first study to evaluate the conjugative and stable bioluminescence vehicle system of pSE-Lux1
in a wide range of Gram-negative bacteria, a system that can provide a useful reporter approach to trace systemic and
gastrointestinal bacterial infections in a mouse model.
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Traditional in vivo animal models to investigate microbi-
ologic infection require sacrifice for tissue smear and
culture. Although numerous methods have been devel-
oped to image bacteria, the clinical applications are still
limited due to inefficient in vivo detections for a long
term of observation without additions of selective antibi-
otics and substrates, such as lucifirins [1]. Recently, bio-
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unless otherwise stated.trace microorganisms in a living animal [2]. Biolumines-
cence system in live bacteria is regulated by a luxABCDE
operon, in which luxAB genes encodes for luciferases and
luxCDE genes encode lipid acid reductases to catalyze the
reduction of long chain lipid acids into aldehyde com-
pounds that are the substrates specific for the catalysation
of luciferases LuxA and LuxB [3].
Recently, many luxABCDE-carrying vectors have been
constructed for bioluminescence assays; however, a steady,
broad-host auto-bioluminescence vehicle is needed, espe-
cially a conjugatable plasmid is preferred to deliver exogen-
ous DNA between bacteria and overcome the difficulty in
transformation for some thick-capsule bacteria, such as
Klebsiella pneumoniae [2,4]. Earlier, we constructed aLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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in combination of a stable conjugative native pSE34 that
include pilX1, pilX2, pilX4, pilX5, pilX6, pilX7, pilX8,
pilX9, pilX10, pilX11, taxA, taxB, and tax of type IV secre-
tion system, with a bioluminescence reporter p3ZLux4 that
contains the luxABCDE-kan operon of pXen-5 (Bioware,
Caliper Life Sciences, USA) and the portion of pGEM®-3Z
(Promega Corporation, USA) with 300–400 copies per bac-
terial cell [5-8]. Although pSE34 carries pir, parGF and
stbDE for plasmid stability and partition, plasmid stability
of pSE34 has not been evaluated [7].
In this study, the bacterial conjugation efficiency and
plasmid stability of pSE-Lux1 were determined in vari-
ous Gram-negative bacteria, and distributions of the
pSE-Lux1-carrying bacteria in Balb/c mice were evalu-
ated by an in vivo imaging system.Methods
Bacterial strains
The Gram-negative bacteria and plasmids used in this study
are listed in Table 1. Bacteria were routinely incubated with
Luria-Bertani (LB) media (Difco™, Becton Dickinson, USA).
Salmonella serovars were verified by the O- and H-antigen
agglutination tests (Difco™). Plasmid was checked using the
alkaline lysis method [9]. Antimicrobial agents ampicillin
(100 μl/ml), chloramphenicol (30 μl/ml), gentamicin (50 μl/
ml), and kanamycin (50 μl/ml) were used for bacterial
selection.Table 1 Gram-negative bacterial species and plasmids used in
chloramphenicol resistance; Gmr: gentamicin resistance; Kmr:
Strains and plasmids Characteristics#
E. coli TOP10 ΔlacX74 araΔ139Δ(ara-leu)
Salmonella Typhimurium
OU5045 Wild type with a virulence plasmid
OU5046 A virulence plasmidless strains derived f
OU5045△sipB OU5045 with sipB deletion; Cmr
OU5046△sipB OU5046 with sipB deletion ; Cmr
Salmonella Choleraesuis OU7085 Clinical isolate; drug-susceptible
Serratia marcescens
CB40 Encapsulated clinical isolate; Cmr
CB47 Encapsulated clinical isolate; Cmr
Acinetobacter baumannii
AB08 Encapsulated clinical isolate; Cmr
AB23 Encapsulated clinical isolate; Cmr
Klebsiella pneumoniae CG354 Encapsulated clinical isolate; Cmr
Plasmids
p3ZLux4 ColE1-typed replicon and lux operon; Ap
pKD46Gm A temperature-sensitive plasmid of λRed
pSE-Lux1 46.3-kb conjugative plasmid with IncX-Mutagenesis in S. Typhimurium
Invasion effector gene sipB gene of Salmonella pathogen-
icity island 1 (SPI-1) was chosen to construct less virulence
mutants of S. Typhimurium via the phage Lambda Red re-
combinase expression system [12,13]. The primer se-
quences were designed according to the sequences of sipB
of S. Typhimurium LT2 (accession number NC_003197)
and cat (a chloramphenicol acetyl transferase-encoding
gene) of pKD3 [13]. The forward sequence SipB-Cm-F (5’-
TGGAGTCTCG TCTGGCGGTA TGGCAGGCGA TG
ATTGAGTC cgcctacctg tgacggaaga-3’) and the reverse se-
quence SipB-Cm-R (5’-GCTGCGGTAT TCGTGACTTC
CATGCCCAAC GCCACTTTAT ccctgccact catcgcagta-3’)
were generated a 932-bp PCR amplicon, where the sipB
gene portion is presented in capital letter and the cat por-
tion in lower case. S. Typhimurium strains OU5045 and
OU5046 had been previously transformed with a Lambda
Red recombinases-carrying pKD46Gm by electroporation
[10,13]. The S. Typhimurium sipB-deleted mutants were
named OU5045△sipB and OU5046△sipB.
Plasmid conjugation and stability
The conjugation test was conducted with a slight mo-
dification of methods described elsewhere [7]. E. coli
TOP10 and S. Typhimurium OU5046 carrying pSE-
Lux1 played as donors, the drug-susceptible recipient
bacteria, including A. baumannii strains AB08 and AB23,
E. coli TOP10, K. pneumoniae strain CG354, S. Typhimur-
ium OU5045 and OU5046, and S. Choleraesuis OU7085,this study# Apr: ampicillin resistance; Cmr:
kanamycin resistance; Strr: streptomycin resistance
Note
Invitrogen®
Ou and Chu [10]
rom OU5045 Ou and Chu [10]
This study
This study






r; Kmr; This study
mutagenesis vector; Gmr Doublet et al. [11]
and ColE1-typed replicon and lux operon; Apr, Kmr; Chen et al. [7]
Table 2 Conjugation efficiency of pSE-Kux1 among
various Gram-negative species
Donor bacteria Recipient bacteria Conjugation
efficiency#
E. coli/pSE-Lux1 A. baumannii AB08 1.2 ± 0.6 × 10−7
A. baumannii AB23 8.1 ± 3.8 × 10−6
E. coli TOP10 1.8 ± 1.6 × 10−4
K. pneumoniae CG354 1.9 ± 1.3 × 10−6
S. Choleraesuis SC7085 7.5 ± 2.4 × 10−3
S. Typhimurium OU5045 1.0 ± 0.8 × 10−6
Serratia marcescens CB40 5.9 ± 5.1 × 10−7
Serratia marcescens CB47 1.2 ± 0.4 × 10−3
S. Typhimurium
OU5046/pSE-Lux1
E. coli TOP10 2.2 ± 1.1 × 10−6
K. pneumoniae CG354 8.4 ± 4.6 × 10−7
S. Typhimurium OU5045 1.4 ± 1.6 × 10−3
#Conjugation efficiencies were determined from three individual tests.
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electroporated with gentamicin-resistant plasmid the
pKD46Gm [11]. Overnight donor and recipient bacteria
were 10-fold diluted with LB broth and then co-cultured at
37°C without agitation for 16 hrs. Transconjugants and
recipient bacteria were counted by plating bacteria on LB
agar containing appropriate antibiotics. The conjugation
efficiency of each recipient bacterium was determined by
dividing the number of transconjugants by the total of
recipients.
Plasmid stability was determined by methods as de-
scribed elsewhere [14]. Bacteria were cultured in LB
broth medium without antibiotic and subcultured twice
a day for a period of four days (D0-D4) in a 1000-fold dilu-
tion (approximate 80 generations in four-day period). The
number of bacteria (CFU) was counted on agar media with
or without kanamycin and ampicillin for both pSE-Lux1
and p3ZLux4 (Table 1) to select the bacteria with or with-
out the plasmid. The plasmid stability was determined by
the ratio of the bacterial survival number on selective media
to the total bacterial number on non-selective media [5,6].
Evaluation of bacterial infection in mice
Animal test of bacterial infection in Balb/c mice was ap-
proved by the Institutional Animal Care and Use Commit-
tee (CGU11-164) of Chang Gung University, Taoyuan,
Taiwan. Overnight-grown bacteria were washed and re-
suspended with phosphate buffered saline (PBS) and then
was used to challenge the mice via intravenous (IV) injec-
tion and oral administration [15,16]. The mice were anes-
thetized by gas anesthesia (3% isoflurane), and then
imaged by the in vivo imaging system IVIS® 100 Series
(Xenogen) in accordance with the guidelines of Guide for
the Care and Use of Laboratory Animals [17]. After ani-
mal experiments or once illness appearances, mice were
euthanized according to the previous guidelines.
For a long-term bioluminescence test of a systemic
bacterial infection using the pSE-Lux1-carrying bacteria
in mice, the mice (n = 3) were intravenously injected
with 107 CFU of K. pneumoniae CG354 (a strain non-
pathogenic to mice). The mice were tested for 6 days
without selective pressures, and then were euthanized by
breaking the neck while still anesthetized.
For the evaluation of gastrointestinal infection of Sal-
monella in mouse, the mice were orally gavaged with
10% sodium bicarbonate to neutralize stomach acid for
30 minutes prior to Salmonella challenge. The mice
were separated into four groups (n = 5 per group) and
each mouse were then orally gavaged with 109 CFU S.
Typhimurium. The strains were wild type OU5045, viru-
lence plasmid-less OU5046, and sipB-deletion mutant
strains OU5045△sipB and OU5046△sipB. The mice were
tested without selective pressures for four hours to
strains OU5045 and OU5046, and for two days tomutants due to the restriction of mouse illness appear-
ance thereafter. The anatomic organs of the tested mice
were analyzed in parallel for IVIS imaging.Statistical analysis
Pair-wise comparison in one-way ANOVA (ANalyses Of
VAriance between groups) test was performed using the
software program of Statistical Product And Service So-
lutions (SPPS 12.0), and followed by a Tukey’s HSD
(Honestly Significant Difference) test to determine the
significance of difference between p3ZLux4 and pSE-
Lux1 in the tests of plasmid stabilities.Results
Plasmid pSE-Lux1-mediated conjugation tests between
Gram-negative bacteria
The conjugation results showed that plasmid pSE-Lux1 en-
abled to be transferred into all tested Gram-negative bac-
teria, even into the clinical mucoid (encapsulated) A.
baumannii, K. pneumoniae, and S. marcescens (Table 2).
The highest conjugation efficiencies of pSE-Lux1 in the
donor E. coli TOP10 were 7.5 ± 2.4 × 10−3 and 1.2 ± 0.4 ×
10−3 for S. Choleraesuis SC7085 and S. marcescens CB47.
Additionally, conjugation efficiencies were observed higher
in the same species than between species; for examples, E.
coli-to-E. coli versus E. coli-to-S. Typhimurium (1.8 ± 1.6 ×
10−4 vs. 1.0 ± 0.8 × 10−6), and conversely, S. Typhimurium-
to-S. Typhimurium versus S. Typhimurium-to-E. coli
(1.4 ± 1.6 × 10−3 vs. 2.2 ± 1.1 × 10−6). Furthermore, con-
jugation efficiency was strain-dependent. Transfer of
pSE-Lux1 differed between two recipient S. marcescens
strains CB47 and CB40 with a respective value of 1.2 ±
0.4 × 10−3 and 5.9 ± 5.1 × 10−7 (Table 2).
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within various bacteria
Plasmid stability of pSE-Lux1 and p3ZLux4 differed
among non-capsulated S. Choleraesuis SC7085, S. Typhi-
murium OU4045 and OU5046, and E. coli TOP10
(Figure 1A). pSE-Lux1 maintained with at least 75% of sta-
bility at four-day duration (around 80 generations) in all
four bacteria; the highest stability was observed in S. Cho-
leraesuis SC7085 (almost 100%). In contrast, p3ZLux4 was
less stable (<14%) than pSE-Lux1 in all tested bacteria
with significant difference between these two plasmids
(P < 0.001). Coincidently, p3ZLux4 was the most stable
in S. Choleraesuis SC7085 than other tested bacteria. In
capsulated K. pneumoniae CG354, A. baumannii AB08
and S. marcescens, p3ZLux4 DNA was failed to trans-
form into these bacteria by electroporation. Therefore,
we only evaluated the stability of pSE-Lux1. The stabil-
ity of pSE-Lux1 was higher in K. pneumoniae CG354
than in A. baumannii AB08 and S. marcescens CB47
(Figure 1B).Figure 1 Plasmid stabilities. (A) The plasmid stabilities of pSE-Lux1 and p
bacteria include S. Choleraesuis SC7085, S. Typhimurium OU5045 and OU50
(P < 0.001). (B) The plasmid stabilities of pSE-Lux1 within the encapsulated
(KP) CG354, and Serratia marcescens (SA) CB47, were tested. D0 represents
calibrated as 100%, proportionally compared to those analyzed at the othe
day one, the day two, the day three, and the day four, respectively.Long-term monitoring of bioluminescence bacterium in
mice with a systemic bacterial infection
Non-pathogenic K. pneumoniae strain CG354 carrying
pSE-Lux1 was used. The bioluminescence signals were
clearly observed from the mice without selective pressures
(Figure 2). Although the signal was gradually weakened
within six-day period, the signal could still be clearly de-
tected at the portion of mouse tail at the sixth day.Bacterial distributions of the route of gastrointestinal
infection in mice
Four S. Typhimurium isogenic strains OU5045, OU5046,
and sipB-deletion mutant strains OU5045△sipB and
OU5046△sipB were transformed with pSE-Lux1. The bio-
luminescence signals from the mice demonstrated that
most bioluminescence Salmonella travelled rapidly from
stomach, small intestine, and large intestine to anal within
four hours, and the bacteria were mostly shed at the 48th
hour post-bacterial inoculation (Figure 3).3ZLux4 are compared within various bacteria for four days. The tested
46, and E. coli TOP10. ***: significance with P value less than 0.001
bacteria, including Acinetobacter baumannii (AB) AB08, K. pneumoniae
the day zero when the stability test was initiated, and its value was
r time periods, including D1, D2, D3, and D4, which are denoted the
Figure 2 A long-term bioluminescence test in mice with a
systemic bacterial infection. The pSE-Lux1-carrying strain CG354 of
K. pneumoniae was intravenously injected into Balb/c mice. The
bioluminescence signals from the mice were monitored via an IVIS
system during the periods from one hour to six days post-systemic
bacterial inoculation. The photos were taken with 0.5-second
exposures. The color bar is indicated beside each IVIS image.
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was observed among the four isogenic strains within
gastrointestinal tracts of mice. The bioluminescencesignals were matched the amount of living bacteria from
the anatomic organs. However, the periods of illness ap-
pearance differed between the sipB-normal and the sipB-
deletion strains (four hours vs. two days post-Salmonella
inoculations). Noteworthily, the bioluminescence signals
present in the portion of stomach organs for the virulence
plasmid-less OU5046, but not in its wild-type OU5045.
Discussion
The green fluorescence protein (GFP)-associated fluores-
cence method and the luciferase-associated biolumines-
cence method are the two major methods for IVIS
imaging system in animal models. Compared to GFP
fluorescence, two advantages of the luxABCDE-mediated
bioluminescence method are A) only metabolically active
and living bacteria may present light, but the dormant
or dead bacteria may not, or weakly, because of their lit-
tle production of aldehyde substrates for luciferase reac-
tions; B) bioluminescence background of this system is
low in animal models [18]. However, the GFP fluores-
cence method has higher sensitivity than biolumines-
cence methods in IVIS system and this advantage is only
available to superficial organs less than 6 mm depth
from the surface of test animals, or fluorescence signals
would be faded [19]. Moreover, auto-fluorescence back-
grounds emitted from animals are high [3]. To overcome
auto-fluorescence, the test animals should get starved
for 3 to 24 hours prior to fluorescence imaging, because
diets may cause significant auto-fluorescence [20]. The
precaution by starvation may limit the application of
GFP-associated methods in IVIS imaging systems, par-
ticularly at the detection sites close to gastrointestinal
tracts.
First bioluminescence image of the lux operon was de-
veloped to study the pathogenesis of S. Typhimurium in
C57BL/6 or BALB/c mice using an artificial plasmid that
contains this operon from Photorhabdus luminescens
[21]. However, the replication origin of this plasmid was
derived from the ColE1 replicon and was unstable with-
out antibiotic pressure. Therefore, three stable photonic
plasmids pCGLS-1 (carrying ColE1 replicon), pAK1-lux
(carrying pBBR1 replicon) and pXEN-1 (carrying both
pC194 and ColE1 replicons) were constructed for the
stability in S. Typhimurium [1]. In this study, a pSE34-
based pSE-Lux1 showed better plasmid stability than
ColE1 replicon-based p3ZLux4 in E. coli, K. pneumo-
niae, and S. enterica. This is probably because pSE-Lux1
carries important genetic elements, including ColE1 and
IncX replicons, conjugation-associated pil operon, and
plasmid maintenance-associated genes pir, parG, parF,
stbD, and stbE [7]. Some other bioluminescence systems
(such as fluc, gluc, or rluc) may be more appropriate
than luxABCDE in various bacteria [2,3,22]. However,
firefly Fluc and Gaussia Gluc require the intravenous
Figure 3 Dynamic distribution of Salmonella in mouse gastrointestinal tracts. The wild type (WT, including OU5045 and OU5046 strains)
and sipB-deletion mutants (including OU5045△sipB and OU5046△sipB strains) of S. Typhimurium were orally administrated into Balb/c mice. The
bioluminescence signals from living mice as well as from their anatomic organs in parallel (lower part of each panel) were monitored at the
first- (A), second- (B), fourth- (C), and 48th-hour (D) periods after Salmonella inoculations. The pictures were taken with 3-minute exposures via
IVIS. The color bar is indicated beside each IVIS image.
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lyzation in vivo, therefore, it only remains relatively as
short as 30 minutes when the peak of bioluminescence
signal reaches a plateau [23].The conjugation efficiencies differed between bacterial
species probably due to difference in enzymatic restric-
tion and modification system. However, the two recipi-
ent S. marcescens strain CB40 and CB47 showed
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difference may be attributed to the different genomic
background or bacterial capsule. With regard to the
bioluminescence patterns of K. pneumoniae mucoid
strain CG354 for a systemic bacterial infection in this
study, the gradual reduction of bioluminescence signals
over the time indicated that strain CG354 was non-
pathogenic to mice. Similar to strain CG354, strain
IA565 of K. pneumoniae, a human clinical isolate, is
known to be non-pathogenic to mice [24]. However, sur-
vey of International Klebsiella Study Group reported
that 69% mucoid clinical strains are pathogenic to mur-
ine [16].
In the bioluminescence patterns of anatomic gastro-
intestinal organs of mice, pSE-Lux1-carrying OU5046
strain produced more signals in the stomach than by the
pSE-Lux1-carrying OU5045 strain were found. It is likely
because the more virulent strain caused more severe in-
flammatory diarrhea to mice, more Salmonella shed
away from stomach and other gastrointestinal organs,
and therefore, the less virulent △sipB mutant remained
more in gastrointestinal tracts. Although Salmonella are
known to enable survive in the acidic environment of
stomach through the induction of the acid tolerance re-
sponse, it still remains unclear why Salmonella can
colonize in the stomach; however, its colonization may
explain why Salmonella can cause stomach cramps in
humans [25,26].
Bioluminescence-related publications have been in-
creasing in application to study in the area of pathogen-
icity, tumorigenicity, biofilm, and dermatology [27-30].
Moreover, the bioluminescence vehicle can be genetic-
ally engineered to carry some other potential exogenous
genes, such as anticancer agents for therapeutic pur-
poses [31].
Conclusion
In this study, a novel stable and conjugative biolumines-
cence pSE-Lux1 vehicle system available in a broad
range of bacteria, even for encapsulated bacteria, is well
developed and applied to investigate the infection route
of pSE-Lux1-carrying bacteria in living mice
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